指南与共识临床免疫质量管理与危急值

意大利临床实验室采用ICAP分类报告ANA模式的实践

Adopting the International Consensus on ANA Patterns (ICAP) classification for reporting: the experience of Italian clinical laboratories.
指南 / 共识 · Clin Chem Lab Med · 2023-10-19

该文基于意大利全国自身抗体诊断调查,分析意大利实验室对国际抗核抗体模式共识(ICAP)命名的依从情况,讨论其优势与不足。ICAP导向报告在意大利实验室广泛使用,有助于 harmonization 和临床沟通,为临床决策提供支持。

要点

  • ICAP命名促进HEp-2 IFA染色模式报告标准化。
  • 意大利实验室广泛采用ICAP导向报告。
  • 标准化报告有助于临床沟通和关键决策。

核心结论

  • ICAP导向报告在意大利实验室广泛使用,是 harmonization 和改善临床沟通的进一步举措。

研究设计与样本

  • 结合意大利全国自身抗体诊断演变调查,分析意大利实验室对ICAP命名的依从性。

主要发现

  • 意大利实验室对ICAP命名依从性有好有坏,ICAP导向报告目前广泛使用。

临床怎么用

  • 采用ICAP命名报告HEp-2 IFA染色模式,以增加实验室结果价值并辅助关键临床决策。

局限性

  • 原文未明确报告具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The indirect immunofluorescence assay on HEp-2 cells (HEp-2 IFA) is still considered the reference method to detect anti-nuclear antibodies (ANA) because of its high sensitivity and represents a relevant tool for the diagnosis of autoimmune rheumatic diseases. During the last decade, the International Consensus on ANA Patterns (ICAP) initiative promoted harmonization and understanding of HEp-2 IFA staining pattern nomenclature, as well as promoting their use in patient care by providing interpretation for HEp-2 IFA test results. In conjunction with a nationwide survey on the evolution of autoantibody diagnostics in autoimmune rheumatic diseases, we focused on the adherence of the Italian laboratories to the ICAP nomenclature analyzing its lights and shadows. The recent ICAP-oriented report, largely used today among Italian laboratories, also represents a further step in harmonizing and improving communication with the clinicians, adding value to laboratory findings and helping with critical clinical decisions.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Infantino M, Bizzaro N, de Melo Cruvinel W, et al. Adopting the International Consensus on ANA Patterns (ICAP) classification for reporting: the experience of Italian clinical laboratories. Clin Chem Lab Med. 2023. PMID: 37852014. doi:10.1515/cclm-2023-0752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。